LoQus23 Therapeutics, based at Granta Park in Cambridge, has stepped up its bid to combat Huntington’s Disease (HD). It has ...
LoQus23 Therapeutics Ltd ("LoQus23"), a biotechnology company investigating small molecule drugs that could stop the pathogenic triplet expansion that is the cause and driver of Huntington's Disease ...
Tecentriq, Avastin Regimen Beats Anti-PD-L1 Monotherapy in MMR-Deficient, MSI-High Colorectal Cancer
Genentech's PD-L1 inhibitor combined with Avastin and chemo improved median progression-free survival by around 20 months ...
Apurinic/apyrmidinic endonuclease 1 (APE1) plays a central role in DNA repair by cleaving the DNA backbone 5′ of AP sites that result from removal of damaged bases. New structural findings on APE1–DNA ...
Scientists are making inroads in understanding one of the central mysteries of human reproduction: Why do women’s eggs ...
Although the year brought a steady stream of new treatments, tests, and cutting-edge science, experts worry about how politics will impact innovation long term.
Audacy on MSN
AI-powered products dominated the 'Worst in Show' categories at this year's CES gadget show
They’re like the Razzies, but for technology. This week, the list of “Worst in Show” gadgets was announced at the Consumer ...
The New Republic on MSNOpinion
What a Lobster Heist Tells Us About Government Failure
Thieves regularly exploit the tangled, under-regulated freight mess that puts food on your plate. The answer is not more ...
The U.S. has over one million unfilled skilled trade jobs. Ford alone struggles to fill 5,000 mechanic positions. Salaries ...
In an era obsessed with authenticity, what we wear is the first language we speak. Yet most leaders remain unconscious of ...
When it comes to insurance, most people know the obvious things that are covered: car accidents, house fires or theft. But it ...
BHPian joybhowmik recently shared this with other enthusiasts:Ruby's first accidentThe Accident:3rd Jan: I was rushing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results